124 related articles for article (PubMed ID: 38241194)
1. APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by NRF2/HO-1.
Mei L; Long J; Wu S; Mei M; Mei D; Qiu H
Anticancer Drugs; 2024 Apr; 35(4):333-343. PubMed ID: 38241194
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
3. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
Lou JS; Zhao LP; Huang ZH; Chen XY; Xu JT; Tai WC; Tsim KWK; Chen YT; Xie T
Phytomedicine; 2021 Jan; 80():153370. PubMed ID: 33113504
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis.
Zheng XJ; Chen WL; Yi J; Li W; Liu JY; Fu WQ; Ren LW; Li S; Ge BB; Yang YH; Zhang YZ; Yang H; Du GH; Wang Y; Wang JH
Acta Pharmacol Sin; 2022 Nov; 43(11):2977-2992. PubMed ID: 35581292
[TBL] [Abstract][Full Text] [Related]
5. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer.
Gai C; Yu M; Li Z; Wang Y; Ding D; Zheng J; Lv S; Zhang W; Li W
J Cell Physiol; 2020 Apr; 235(4):3329-3339. PubMed ID: 31541463
[TBL] [Abstract][Full Text] [Related]
6. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
[TBL] [Abstract][Full Text] [Related]
7. NRF2 regulates the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via FOCAD-FAK signaling pathway.
Liu P; Wu D; Duan J; Xiao H; Zhou Y; Zhao L; Feng Y
Redox Biol; 2020 Oct; 37():101702. PubMed ID: 32898818
[TBL] [Abstract][Full Text] [Related]
8. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer.
Chen Y; Jiang Z; Zhang C; Zhang L; Chen H; Xiao N; Bai L; Liu H; Wan J
J Biol Chem; 2024 Apr; 300(4):106793. PubMed ID: 38403250
[TBL] [Abstract][Full Text] [Related]
9. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer.
Shen X; Zhao Y; Liu G; Zhou HL; Fan J; Zhang L; Li YL; Wang Y; Liang J; Xu ZX
Life Sci; 2020 Sep; 256():117923. PubMed ID: 32522567
[TBL] [Abstract][Full Text] [Related]
11. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
12. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
[TBL] [Abstract][Full Text] [Related]
13. Suppressive role of microRNA-130b-3p in ferroptosis in melanoma cells correlates with DKK1 inhibition and Nrf2-HO-1 pathway activation.
Liao Y; Jia X; Ren Y; Deji Z; Gesang Y; Ning N; Feng H; Yu H; Wei A
Hum Cell; 2021 Sep; 34(5):1532-1544. PubMed ID: 34117611
[TBL] [Abstract][Full Text] [Related]
14. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
[No Abstract] [Full Text] [Related]
15. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1.
Dong H; Qiang Z; Chai D; Peng J; Xia Y; Hu R; Jiang H
Aging (Albany NY); 2020 Jun; 12(13):12943-12959. PubMed ID: 32601262
[TBL] [Abstract][Full Text] [Related]
16. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.
Kim JW; Kim MJ; Han TH; Lee JY; Kim S; Kim H; Oh KJ; Kim WK; Han BS; Bae KH; Ban HS; Bae SH; Lee SC; Lee H; Lee EW
Cell Death Dis; 2023 Aug; 14(8):567. PubMed ID: 37633973
[TBL] [Abstract][Full Text] [Related]
17. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
18. ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury.
Rao J; Qian X; Li G; Pan X; Zhang C; Zhang F; Zhai Y; Wang X; Lu L
Am J Transplant; 2015 Jan; 15(1):76-87. PubMed ID: 25359217
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
